Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (632)
  2. Journal Article (373)
  3. Research Letter (17)
  4. Review (15)
  5. Guidelines (5)
  6. Editorial (4)
  7. Book Section (3)
  8. Correspondence (3)
Groups
  1. Bone Marrow Transplant (1052)
  2. Center for Hematologic Malignancies (1052)
  3. Department of Medicine (1052)
  4. Hematologic Malignancies, Division of (1052)
  5. Survivorship Research (686)
  6. CTCR Scholars (541)

More Groups

People
  1. Miguel-Angel Perales (422)
  2. Sean Devlin (372)
  3. Gunjan Shah (298)
  4. Michael Scordo (267)
  5. Heather Landau (253)
  6. Ann Jakubowski (240)

More People

Years
  1. 2025 (11)
  2. 2024 (55)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (304)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (384)
  2. American Society of Hematology (337)
  3. Nature Publishing Group (108)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1052)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Low target antigen expression mediates resistance to BCMA CAR T cell therapy
    Meeting Abstract

    Perica, K.; Nataraj, S.; Sjojstrand, M. L.; Nagel, K.; Pavkovic, E.; Payson, E.; Cuenca, A.; Patel, A.; Chung, D.; Mailankody, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Journal Article

    Dahi, P. B.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Chinapen, S. A.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (Ide-cel) versus standard regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 a phase 3 randomized controlled trial (RCT)
    Meeting Abstract

    Scheid, C.; Otero, P. R.; Ailawadhi, S.; Arnulf, B.; Patel, K.; Cavo, M.; Nooka, A. K.; Manier, S.; Callander, N.; Costa, L. J.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Patient reported outcomes in triple class exposed, relapsed/refractory multiple myeloma (TCE RRMM) patients in KarMMa 3 trial (Phase 3 RCT): Idecabtagene Vicleucel (ide-cel) versus standard regimens
    Meeting Abstract

    Einsele, H.; Delforge, M.; Patel, K.; Eliason, L.; Dhanda, D.; Shi, L.; Guo, S.; Marshall, T.; Arnulf, B.; Cavo, M.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Evaluation of urine BKV by day 40 posthematopoietic cell transplant as predictor of BKV-associated hemorrhagic cystitis
    Meeting Abstract

    Lee, Y. J.; Scordo, M.; Glezerman, I.; Han, G.; Perales, M. A.; Giralt, S.; Jakubowski, A.; Papanicolaou, G.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Geriatric assessment and outcomes of allogeneic hematopoietic cell transplantation in older patients
    Meeting Abstract

    Dahi, P. B.; Shahrokni, A.; Flynn, J.; Devlin, S. M.; Chinapen, S. A.; Ayala, J.; Brown, S.; Bugen, S.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Response rates and outcomes in newly-diagnosed multiple myeloma (NDMM) patient subgroups receiving RVd±ASCT plus lenalidomide maintenance until progression in the phase 3 determination trial
    Meeting Abstract

    Hassoun, H.; Jacobus, S. J.; Voorhees, P. M.; Zonder, J. A.; Lonial, S.; Raje, N.; Medvedova, E.; McCarthy, P. L.; Libby, E. N.; Reeves, B.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A randomized phase 3 study of allogeneic HCT with Iomab-B versus conventional care in older patients with active, relapsed/refractory AML: Pivotal SIERRA trial results
    Meeting Abstract

    Giralt, S.; Gyurkocza, B.; Seropian, S.; Choe, H.; Litzow, M.; Abboud, C.; Koshy, N.; Stiff, P.; Tomlinson, B.; Abhyankar, S.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A prospective study of allogeneic stem cell transplantation of A/B T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies
    Meeting Abstract

    Tamari, R.; Flynn, J.; Shaffer, B.; Jakubowski, A.; Papadopoulos, E.; Devlin, S.; Lin, R.; Giralt, S.; Perales, M. A.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save